BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rigoli L, Caruso RA. Inflammatory bowel disease in pediatric and adolescent patients: A biomolecular and histopathological review. World J Gastroenterol 2014; 20(30): 10262-10278 [PMID: 25132743 DOI: 10.3748/wjg.v20.i30.10262] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Ahmed AH, Sonnenburg K, Foli KJ, Walters B. Managing Ulcerative Colitis in the Adolescent: Highlighting the Developmental and Self-management Needs. Holist Nurs Pract 2016;30:39-46. [PMID: 26633725 DOI: 10.1097/HNP.0000000000000123] [Reference Citation Analysis]
2 Cunningham KE, Novak EA, Vincent G, Siow VS, Griffith BD, Ranganathan S, Rosengart MR, Piganelli JD, Mollen KP. Calcium/calmodulin-dependent protein kinase IV (CaMKIV) activation contributes to the pathogenesis of experimental colitis via inhibition of intestinal epithelial cell proliferation. FASEB J 2019;33:1330-46. [PMID: 30113881 DOI: 10.1096/fj.201800535R] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
3 Delday M, Mulder I, Logan ET, Grant G. Bacteroides thetaiotaomicron Ameliorates Colon Inflammation in Preclinical Models of Crohn's Disease. Inflamm Bowel Dis 2019;25:85-96. [PMID: 30215718 DOI: 10.1093/ibd/izy281] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 19.5] [Reference Citation Analysis]
4 Nemati S, Teimourian S. An Overview of Inflammatory Bowel Disease: General Consideration and Genetic Screening Approach in Diagnosis of Early Onset Subsets. Middle East J Dig Dis. 2017;9:69-80. [PMID: 28638582 DOI: 10.15171/mejdd.2017.54] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
5 Furey TS, Sethupathy P, Sheikh SZ. Redefining the IBDs using genome-scale molecular phenotyping. Nat Rev Gastroenterol Hepatol. 2019;16:296-311. [PMID: 30787446 DOI: 10.1038/s41575-019-0118-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 12.0] [Reference Citation Analysis]
6 Nemati S, Teimourian S, Tabrizi M, Najafi M, Dara N, Imanzadeh F, Ahmadi M, Aghdam MK, Tavassoli M, Rohani P, Madani SR, de Boer M, Kuijpers TW, Roos D. Very early onset inflammatory bowel disease: Investigation of the IL-10 signaling pathway in Iranian children. Eur J Med Genet 2017;60:643-9. [PMID: 28864178 DOI: 10.1016/j.ejmg.2017.08.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
7 Béres NJ, Szabó D, Kocsis D, Szűcs D, Kiss Z, Müller KE, Lendvai G, Kiss A, Arató A, Sziksz E, Vannay Á, Szabó AJ, Veres G. Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:327-35. [PMID: 26752469 DOI: 10.1097/MIB.0000000000000687] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
8 Mottawea W, Chiang CK, Mühlbauer M, Starr AE, Butcher J, Abujamel T, Deeke SA, Brandel A, Zhou H, Shokralla S, Hajibabaei M, Singleton R, Benchimol EI, Jobin C, Mack DR, Figeys D, Stintzi A. Altered intestinal microbiota-host mitochondria crosstalk in new onset Crohn's disease. Nat Commun 2016;7:13419. [PMID: 27876802 DOI: 10.1038/ncomms13419] [Cited by in Crossref: 165] [Cited by in F6Publishing: 154] [Article Influence: 33.0] [Reference Citation Analysis]
9 Petruo VA, Zeißig S, Schmelz R, Hampe J, Beste C. Specific neurophysiological mechanisms underlie cognitive inflexibility in inflammatory bowel disease. Sci Rep 2017;7:13943. [PMID: 29066846 DOI: 10.1038/s41598-017-14345-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
10 Vaiopoulou A, Gazouli M, Papadopoulou A, Anagnostopoulos AK, Karamanolis G, Theodoropoulos GE, M’Koma A, Tsangaris GT. Serum protein profiling of adults and children with Crohn disease. J Pediatr Gastroenterol Nutr. 2015;60:42-47. [PMID: 25250685 DOI: 10.1097/mpg.0000000000000579] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
11 Schnell A, Schwarz B, Wahlbuhl M, Allabauer I, Hess M, Weber S, Werner F, Schmidt H, Rechenauer T, Siebenlist G, Kaspar S, Ehrsam C, Rieger D, Rückel A, Metzler M, Christoph J, Woelfle J, Rascher W, Hoerning A. Distribution and Cytokine Profile of Peripheral B Cell Subsets Is Perturbed in Pediatric IBD and Partially Restored During a Successful IFX Therapy. Inflamm Bowel Dis 2021;27:224-35. [PMID: 32185399 DOI: 10.1093/ibd/izaa054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Fléjou JF. [Histoseminar on inflammatory bowel diseases (IBD): Case no 03]. Ann Pathol 2017;37:293-7. [PMID: 28739216 DOI: 10.1016/j.annpat.2017.06.006] [Reference Citation Analysis]
13 Villanacci V, Reggiani-Bonetti L, Caprioli F, Saragoni L, Salviato T, Mescoli C, Canavese G, Manenti S, Spada E, Baron L, Leoncini G, Cadei M, Battista S, Armuzzi A. Histopathology of inflammatory bowel disease - Position statement of the Pathologists of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Group of Gastrointestinal Pathologists (GIPAD-SIAPEC). Dig Liver Dis 2020;52:262-7. [PMID: 31884010 DOI: 10.1016/j.dld.2019.11.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
14 Matondo A, Kim SS. Targeted-mitochondria antioxidants therapeutic implications in inflammatory bowel disease. Journal of Drug Targeting 2018;26:1-8. [DOI: 10.1080/1061186x.2017.1339196] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Holmes EA, Rodney Harris RM, Lucas RM. Low Sun Exposure and Vitamin D Deficiency as Risk Factors for Inflammatory Bowel Disease, With a Focus on Childhood Onset. Photochem Photobiol 2019;95:105-18. [PMID: 30155900 DOI: 10.1111/php.13007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
16 Giannoudaki E, Gargan S, Hussey S, Long A, Walsh PT. Opportunities to Target T Cell Trafficking in Pediatric Inflammatory Bowel Disease. Front Pediatr 2021;9:640497. [PMID: 33816403 DOI: 10.3389/fped.2021.640497] [Reference Citation Analysis]
17 Novak EA, Mollen KP. Mitochondrial dysfunction in inflammatory bowel disease. Front Cell Dev Biol. 2015;3:62. [PMID: 26484345 DOI: 10.3389/fcell.2015.00062] [Cited by in Crossref: 98] [Cited by in F6Publishing: 98] [Article Influence: 16.3] [Reference Citation Analysis]
18 Herzog D, Fournier N, Buehr P, Rueger V, Koller R, Heyland K, Nydegger A, Braegger CP; Swiss IBD Cohort Study Group. Prevalence of intestinal complications in inflammatory bowel disease: a comparison between paediatric-onset and adult-onset patients. Eur J Gastroenterol Hepatol 2017;29:926-31. [PMID: 28471820 DOI: 10.1097/MEG.0000000000000896] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
19 Judit Béres N, Kiss Z, Müller KE, Cseh Á, Veres-Székely A, Lippai R, Benkő R, Bartha Á, Heininger S, Vannay Á, Sziksz E, Veres G, Horváth EM. Role of microRNA-223 in the regulation of poly(ADP-ribose) polymerase in pediatric patients with Crohn's disease. Scand J Gastroenterol 2018;53:1066-73. [PMID: 30299179 DOI: 10.1080/00365521.2018.1498915] [Reference Citation Analysis]
20 Tran DN, Go SM, Park SM, Jung EM, Jeung EB. Loss of Nckx3 Exacerbates Experimental DSS-Induced Colitis in Mice through p53/NF-κB Pathway. Int J Mol Sci 2021;22:2645. [PMID: 33807999 DOI: 10.3390/ijms22052645] [Reference Citation Analysis]
21 Johnson LE, Lee MJ, Turner-Moore T, Grinsted Tate LR, Brooks AJ, Tattersall RS, Jones GL, Lobo AJ. Systematic Review of Factors Affecting Transition Readiness Skills in Patients with Inflammatory Bowel Disease. J Crohns Colitis 2021;15:1049-59. [PMID: 33252669 DOI: 10.1093/ecco-jcc/jjaa245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Jafri L, Siddiqui A, Sidddique S, Parkash O, Kausar R, Majid H. Clinical Spectrum in a Cohort of Patients With High Fecal Calprotectin Levels. Cureus 2020;12:e11314. [PMID: 33282590 DOI: 10.7759/cureus.11314] [Reference Citation Analysis]
23 Béres NJ, Kiss Z, Sztupinszki Z, Lendvai G, Arató A, Sziksz E, Vannay Á, Szabó AJ, Müller KE, Cseh Á, Boros K, Veres G. Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease. Dig Liver Dis 2017;49:378-87. [PMID: 28077249 DOI: 10.1016/j.dld.2016.12.022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]